Selected research
Industry Research
Dry Eye Industry Research Report 2026
Market perspective
The global Dry Eye market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Dry Eye is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Dry Eye is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Dry Eye is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Dry Eye include Johnson & Johnson, Novartis, United Laboratories, Jianfeng Group, URSAPHARM, Thea pharmaceuticals, Sun Pharmaceutical, SIMILASAN and Santen Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Dry Eye market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Dry Eye Market by Company
Johnson & Johnson
Novartis
United Laboratories
Jianfeng Group
URSAPHARM
Thea pharmaceuticals
Sun Pharmaceutical
SIMILASAN
Santen Pharma
Bausch & Lomb
Allergan
Alcon
Akorn
Dry Eye Segment by Type
Artificial Tears
Anti-inflammatory Drugs
Others
Dry Eye Segment by Application
Hospital
Retail Pharmacy
Others
Dry Eye Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Eye market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Eye and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Eye.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dry Eye manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dry Eye by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dry Eye in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Artificial Tears
- Anti-inflammatory Drugs
- Others
Applications
- Hospital
- Retail Pharmacy
- Others
Companies covered
- Johnson & Johnson
- Novartis
- United Laboratories
- Jianfeng Group
- URSAPHARM
- Thea pharmaceuticals
- Sun Pharmaceutical
- SIMILASAN
- Santen Pharma
- Bausch & Lomb
- Allergan
- Alcon
- Akorn
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Dry Eye Market Size (2021-2032)
- 2.2.2 Global Dry Eye Sales (2021-2032)
- 2.2.3 Global Dry Eye Market Average Price (2021-2032)
- 2.3 Dry Eye by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Artificial Tears
- 2.3.3 Anti-inflammatory Drugs
- 2.3.4 Others
- 2.4 Dry Eye by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Retail Pharmacy
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Dry Eye Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Dry Eye Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Dry Eye Revenue of Manufacturers (2021-2026)
- 3.4 Global Dry Eye Average Price by Manufacturers (2021-2026)
- 3.5 Global Dry Eye Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Dry Eye, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Dry Eye, Product Type & Application
- 3.8 Global Manufacturers of Dry Eye, Established Date
- 3.9 Global Dry Eye Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Johnson & Johnson
- 4.1.1 Johnson & Johnson Company Information
- 4.1.2 Johnson & Johnson Business Overview
- 4.1.3 Johnson & Johnson Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Johnson & Johnson Dry Eye Product Portfolio
- 4.1.5 Johnson & Johnson Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Dry Eye Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 United Laboratories
- 4.3.1 United Laboratories Company Information
- 4.3.2 United Laboratories Business Overview
- 4.3.3 United Laboratories Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 United Laboratories Dry Eye Product Portfolio
- 4.3.5 United Laboratories Recent Developments
- 4.4 Jianfeng Group
- 4.4.1 Jianfeng Group Company Information
- 4.4.2 Jianfeng Group Business Overview
- 4.4.3 Jianfeng Group Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jianfeng Group Dry Eye Product Portfolio
- 4.4.5 Jianfeng Group Recent Developments
- 4.5 URSAPHARM
- 4.5.1 URSAPHARM Company Information
- 4.5.2 URSAPHARM Business Overview
- 4.5.3 URSAPHARM Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 URSAPHARM Dry Eye Product Portfolio
- 4.5.5 URSAPHARM Recent Developments
- 4.6 Thea pharmaceuticals
- 4.6.1 Thea pharmaceuticals Company Information
- 4.6.2 Thea pharmaceuticals Business Overview
- 4.6.3 Thea pharmaceuticals Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Thea pharmaceuticals Dry Eye Product Portfolio
- 4.6.5 Thea pharmaceuticals Recent Developments
- 4.7 Sun Pharmaceutical
- 4.7.1 Sun Pharmaceutical Company Information
- 4.7.2 Sun Pharmaceutical Business Overview
- 4.7.3 Sun Pharmaceutical Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sun Pharmaceutical Dry Eye Product Portfolio
- 4.7.5 Sun Pharmaceutical Recent Developments
- 4.8 SIMILASAN
- 4.8.1 SIMILASAN Company Information
- 4.8.2 SIMILASAN Business Overview
- 4.8.3 SIMILASAN Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SIMILASAN Dry Eye Product Portfolio
- 4.8.5 SIMILASAN Recent Developments
- 4.9 Santen Pharma
- 4.9.1 Santen Pharma Company Information
- 4.9.2 Santen Pharma Business Overview
- 4.9.3 Santen Pharma Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Santen Pharma Dry Eye Product Portfolio
- 4.9.5 Santen Pharma Recent Developments
- 4.10 Bausch & Lomb
- 4.10.1 Bausch & Lomb Company Information
- 4.10.2 Bausch & Lomb Business Overview
- 4.10.3 Bausch & Lomb Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Bausch & Lomb Dry Eye Product Portfolio
- 4.10.5 Bausch & Lomb Recent Developments
- 4.11 Allergan
- 4.11.1 Allergan Company Information
- 4.11.2 Allergan Business Overview
- 4.11.3 Allergan Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Allergan Dry Eye Product Portfolio
- 4.11.5 Allergan Recent Developments
- 4.12 Alcon
- 4.12.1 Alcon Company Information
- 4.12.2 Alcon Business Overview
- 4.12.3 Alcon Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Alcon Dry Eye Product Portfolio
- 4.12.5 Alcon Recent Developments
- 4.13 Akorn
- 4.13.1 Akorn Company Information
- 4.13.2 Akorn Business Overview
- 4.13.3 Akorn Dry Eye Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Akorn Dry Eye Product Portfolio
- 4.13.5 Akorn Recent Developments
5 Global Dry Eye Market Scenario by Region
- 5.1 Global Dry Eye Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Dry Eye Sales by Region: 2021-2032
- 5.2.1 Global Dry Eye Sales by Region: 2021-2026
- 5.2.2 Global Dry Eye Sales by Region: 2027-2032
- 5.3 Global Dry Eye Revenue by Region: 2021-2032
- 5.3.1 Global Dry Eye Revenue by Region: 2021-2026
- 5.3.2 Global Dry Eye Revenue by Region: 2027-2032
- 5.4 North America Dry Eye Market Facts & Figures by Country
- 5.4.1 North America Dry Eye Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Dry Eye Sales by Country (2021-2032)
- 5.4.3 North America Dry Eye Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Dry Eye Market Facts & Figures by Country
- 5.5.1 Europe Dry Eye Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Dry Eye Sales by Country (2021-2032)
- 5.5.3 Europe Dry Eye Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.5.9 Nordic Countries
- 5.6 Asia Pacific Dry Eye Market Facts & Figures by Country
- 5.6.1 Asia Pacific Dry Eye Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Dry Eye Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Dry Eye Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Dry Eye Market Facts & Figures by Country
- 5.7.1 South America Dry Eye Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Dry Eye Sales by Country (2021-2032)
- 5.7.3 South America Dry Eye Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Dry Eye Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Dry Eye Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Dry Eye Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Dry Eye Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Dry Eye Sales by Type (2021-2032)
- 6.1.1 Global Dry Eye Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Dry Eye Sales Market Share by Type (2021-2032)
- 6.2 Global Dry Eye Revenue by Type (2021-2032)
- 6.2.1 Global Dry Eye Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Dry Eye Revenue Market Share by Type (2021-2032)
- 6.3 Global Dry Eye Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Dry Eye Sales by Application (2021-2032)
- 7.1.1 Global Dry Eye Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Dry Eye Sales Market Share by Application (2021-2032)
- 7.2 Global Dry Eye Revenue by Application (2021-2032)
- 7.2.1 Global Dry Eye Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Dry Eye Revenue Market Share by Application (2021-2032)
- 7.3 Global Dry Eye Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Dry Eye Value Chain Analysis
- 8.1.1 Dry Eye Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Dry Eye Production Mode & Process
- 8.2 Dry Eye Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Dry Eye Distributors
- 8.2.3 Dry Eye Customers
9 Global Dry Eye Analyzing Market Dynamics
- 9.1 Dry Eye Industry Trends
- 9.2 Dry Eye Industry Drivers
- 9.3 Dry Eye Industry Opportunities and Challenges
- 9.4 Dry Eye Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst